Is Lumiradx Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: LMDX) stock is to Buy LMDX stock.
Out of 3 analysts, 1 (33.33%) are recommending LMDX as a Strong Buy, 1 (33.33%) are recommending LMDX as a Buy, 1 (33.33%) are recommending LMDX as a Hold, 0 (0%) are recommending LMDX as a Sell, and 0 (0%) are recommending LMDX as a Strong Sell.
What is LMDX's forecast return on equity (ROE) for 2023-2024?
(NASDAQ: LMDX) forecast ROE is -62.41%, which is considered weak.
What is LMDX's Price Target?
According to 3 Wall Street analysts that have issued a 1 year LMDX price target, the average LMDX price target is $1.42, with the highest LMDX stock price forecast at $2.70 and the lowest LMDX stock price forecast at $0.75.
On average, Wall Street analysts predict that Lumiradx's share price could reach $1.42 by Aug 28, 2024. The average Lumiradx stock price prediction forecasts a potential upside of 559.07% from the current LMDX share price of $0.22.
What is LMDX's forecast return on assets (ROA) for 2023-2024?
(NASDAQ: LMDX) forecast ROA is -39.3%, which is lower than the forecast US Diagnostics & Research industry average of 11.28%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.